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INTRODUCTION
Insult to the spinal cord initiates a dev-
astating cascade of concomitant events
that include anatomical, physiological,
and neurochemical changes often leading
to neuronal cell death and syrinx forma-
tion (1-4). Loss of motor function, altered
sensory function, and/or development of
chronic or neuropathic pain may develop
depending on the location and severity
of injury (5-7). Chronic central pain fol-
lowing spinal cord injury (SCI) occurs in
60% to 80% of SCI patients and is se-
verely compromising, to both adjustment
after injury and patient quality of life (8).
Numerous neurosurgical, pharmacologi-
cal, psychological, and physiological ap-
proaches have been explored, with lim-
ited success, to alleviate central pain fol-
lowing injury. Narcotic analgesics remain
the most common approach in the man-
agement of moderate to severe pain (9);
however, adverse side effects and the po-
tential for addiction or tolerance to phar-
macological modalities have led to
guarded use of these agents in pain man-
agement involving continuous long-term
treatment (9,10). Furthermore, these
agents appear to be relatively ineffective
in controlling more severe chronic pain
syndromes, particularly central pain (11).
Thus, a clear need exists for more effica-
cious and safer approaches in long-term
chronic pain therapies.
In recent years, a rodent model of
chronic pain following SCI has been de-
veloped and thoroughly characterized.
The excitotoxic SCI model, developed by
Yezierski and colleagues (4), has been
used for the study of chronic pain syn-
dromes following SCI. In this model, an
intraspinal microinjection of the mixed
AMPA/metabotropic glutamate receptor
agonist quisqualic acid (QUIS) produces
progressive pathological changes (i.e.,
neuronal loss, astrocytic scarring, spinal
cavitations, and prominent inflammatory
response) that closely resemble those ob-
served following traumatic or ischemic
SCI. Importantly, this model results in
well-characterized pain behaviors that
allow for a broad analysis of sensory dys-
function following injury (12).
It has been suggested that embryonic
stem (ES) cells possess great potential for
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Embryonic stem (ES) cells have been investigated in repair of the CNS following neuronal injury and disease; however, the ef-
ficacy of these cells in treatment of postinjury pain is far from clear. In this study, we evaluated the therapeutic potential of pred-
ifferentiated mouse ES cells to restore sensory deficits following spinal cord injury (SCI) in mice. The pain model used unilateral in-
traspinal injection of quisqualic acid (QUIS) into the dorsal horn between vertebral levels T13 and L1. Seven days later, 60,000
predifferentiated ES cells or media were transplanted into the site of the lesion. Histological analysis at 7, 14, and 60 days post-
transplantation revealed that animals receiving ES cell transplants suffered significantly less tissue damage than animals receiv-
ing media alone. Transplanted cells provided immediate effects on both spontaneous and evoked pain behaviors. Treatment
with ES cells resulted in 0% (n = 28) excessive grooming behavior versus 60% (18 of 30) in media-treated animals. In the acetone
test (to assess thermal allodynia), mice recovered to preinjury levels by 12 days after ES cell transplant, whereas control animals
injected with media after SCI did not show any improvement up to 60 days. Similarly, the von Frey test (to assess mechanical al-
lodynia) and the formalin test (to assess nociceptive hyperalgesia) showed that transplantation of predifferentiated ES cells sig-
nificantly reduced these pain behaviors following injury. Here we show that predifferentiated ES cells act in a neuroprotective
manner and provide antinociceptive and therapeutic effects following excitotoxic SCI.
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repair of the damaged central nervous
system (CNS). Several studies have
shown ES cells to survive, propagate,
and even provide some beneficial effects
in the rodent CNS after experimental in-
jury (13-22). For treatment of central pain
syndromes, there have also been reports
using transplantation of GABAergic and
serotonergic precursor cells of different
origin (23-25). In a recent report, trans-
plantation of naive neural stem cells de-
rived from adult rat spinal cords signifi-
cantly improved motor function after
spinal cord injury (26). Unfortunately, it
also caused aberrant host fiber sprouting
associated with allodynia-like hypersen-
sitivity of nonaffected forepaws.
Therefore, given the highly reactive envi-
ronment that exists following injury as
well as the suggestion that glial cues pre-
dominate at the site of injury, directed
predifferentiation of ES cells into neu-
ronal progenitors may greatly improve
survivability and effect following trans-
plantation. In a recent collaborative
study, we demonstrated that predifferen-
tiated ES cells could provide sensorimo-
tor improvement following traumatic
brain injury without any side effects (27).
Using a similar differentiation protocol,
we attempted to investigate the potential
of these cells to address pain syndromes
that occur following SCI.
The focus of our study was to utilize
mouse ES cells predifferentiated into
neuronal and glial progenitors for treat-
ment of pain syndromes following SCI.
In the first stage of research, we used a
modified retinoic acid protocol (28) to in-
duce differentiation of mouse embryonic
stem cells into neuronal and glial precur-
sors suitable for transplantation. In the
second stage of this project, we trans-
planted these cells into injured spinal
cord and conducted a battery of sensory
behavioral tests to evaluate associated
pain syndromes including examination
of both spontaneous and evoked pain be-
haviors. The results of this study demon-
strate for the first time that neural pro-
genitors generated from mouse ES cells
can limit secondary tissue damage fol-
lowing SCI, alleviate induced pain be-
haviors, and prevent the development of
chronic central pain.
MATERIALS AND METHODS
Embryonic Stem Cell Culture
Undifferentiated, pluripotent mouse
embryonic stem (ES) cells (D3 cell line;
American Type Culture Collection,
Manassas, VA) were utilized in this
study. Murine ES cells were grown, prop-
agated, and differentiated into neural
precursors using retinoic acid.
Murine ES cells were transfected
with the pEGFP-N3 construct
(Clontech, Palo Alto, CA, USA) in the
presence of FuGENE 6 (Roche,
Indianapolis, IN, USA) as described
(27). Transfected colonies were then se-
lected in the presence of 200 mg/mL
G418 (Sigma) and FACS sorted on a
FACSVantage SE flow cytometry sys-
tem (Becton Dickinson) to achieve 90%
of GFP-labeled cells. Transgenic D3
cells were further used for induction of
neural cells.
Cells were cultured in gelatinized
25-cm flasks in a medium consisting of
Dulbecco’s modified Eagle’s medium
(DMEM), 15% fetal bovine serum (FBS)
(ES grade), 100 units/mL penicillin,
100 μg/mL streptomycin, 2 mM
L-glutamine, 0.1 mM nonessential amino
acids, 10 ng/mL murine leukemia in-
hibitory factor (all from Stem Cell
Technologies, Vancouver, Canada), and
100 μM β-mercaptoethanol (Sigma
Chemical, St. Louis, MO, USA). Cells
were passaged at approximately 80% to
90% confluence, usually every other day.
Our published 4–/4+ protocol was used
for differentiation of ES cells (28,29).
Briefly, during differentiation induction
maintenance medium was exchanged for
differentiation medium (Iscove’s modi-
fied Dulbecco’s medium, 15% FBS,
L-glutamine [2 mM], nonessential amino
acids [0.1 mM], 100 units/mL penicillin,
and 100 μg/mL streptomycin, but no LIF
or β-mercaptoethanol). Passaged cells
(2.5 × 106) in differentiation medium
were placed in 100-mm, low-adhesion
Petri dishes where they began to form
embryoid bodies (EBs) after 1 to 2 days.
The medium was replaced with fresh
medium every 2 days. After 4 days, EBs
were gently transferred to a 15-mL tube
and allowed to stand until the EBs set-
tled to the bottom (~10 min). The me-
dium was replaced and EBs were trans-
ferred back to the original dish by
pipetting. At day 5, all-trans retinoic
acid (Sigma) (1 × 10–6 M) was added to
the culture. Medium was changed and
RA treatment was repeated on day 7.
On day 9, EBs were collected and
seeded on poly-L-ornithine/fibronectin-
coated flasks in differentiation medium.
The next day, medium was replaced
with differentiation/Neurobasal plus
B27 supplement 1:1. The cells were cul-
tured for another 2 to 3 days and then
harvested for the injections. The me-
dium was aspirated and discarded, and
the cells were washed with PBS,
trypsinized, and centrifuged in
DMEM/FBS, after which they were re-
suspended in Neurobasal medium plus
B27. At this point, the cells could be
transplanted or plated for immunocyto-
chemical analysis. We routinely produce
~60% neurons and less than 40% of glial
cells using this protocol (28-30).
Animal Surgery
Mature 8-week-old male mice (outbred
ICR strain; Charles River Laboratories,
Wilmington, MA, USA) were housed
with unlimited access to food and water
and a 12-h light/dark schedule. All pro-
cedures, behavioral tests and tissue col-
lection methods were approved by the
East Carolina University Animal Care
and Use Committee.
The technique of intraspinal injection
was similar to that described in previous
reports (4,45). Mice were prepared for
surgery by shaving the back and wash-
ing the surgical area with betadine solu-
tion (Purdue Frederick, Stamford, CT,
USA). Surgery was performed under
isoflurane anesthesia (1% to 4% inhala-
tion to effect). After a midline incision,
the spinal muscles were dissected away
from the spinal column. The spinous
process and vertebral lamina of one
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spinal segment were removed, exposing
the spinal cord. Unilateral microinjec-
tions were made in a single segment at
spinal levels ranging from T12 to L2.
Glass micropipettes (tip diameter
10-15 μm) attached to a 10-μL Hamilton
syringe were used for microinjections.
The syringe was mounted on a micro-
injector (Kopf 5000; David Kopf Instru-
ments, Tujunga, CA, USA) attached to a
micromanipulator. Injections were made
between the dorsal vein and dorsal root
entry zone at a depth of 250 to 350 μm
below the surface of the cord. Each ani-
mal received 0.6 μL of 125 mM QUIS
(Sigma) in PBS injected over 3 min (three
tracks of 0.2 μL separated by 0.3 mm, par-
allel to the long axis of the cord). This
amount of QUIS produces overgrooming
behavior in ~60% of animals according to
previous studies (31,32). After microinjec-
tions, muscles were sutured in layers and
the overlying skin was closed with sta-
ples. A subcutaneous injection of 0.9%
saline was given to prevent dehydration,
and a topical antibiotic was applied to the
surgical wound. Animals were returned
to their home cages where they were al-
lowed to recover for 7 days before further
surgical procedures.
After a 1-week period of recovery,
mice were anesthetized with isoflurane
and washed with betadine. Skin staples
and sutures were removed, and scar tis-
sue at the site of previous injury was
gently excised revealing sites of prior
QUIS microinjections. Similar to the pre-
ceding microinjections, predifferentiated
mouse ES cells were delivered into the
injury (three tracks of 0.2 μL separated
by 0.3 mm, parallel to the long axis of the
cord) over a 3- to 5-min time. ES cells
had to be delivered more gradually than
QUIS due to the viscous nature of the
concentration (~100,000 cells/μL).
Throughout the procedure and before in-
jections, cells were kept at 37 °C and re-
suspended gently to prevent clumping.
Media-treated animals received similar
microinjections of QUIS and, 7 days later,
microinjections of cell differentiation
media equal in volume and location.
Control animals did not receive any in-
jections. After the injections, muscles
were sutured and the skin was closed
using staples. Topical antibiotic was ap-
plied to the surgical wound.
Behavioral Tests
Excessive grooming behavior.
Animals were assessed daily for the
presence of excessive grooming behavior
(self-directed biting and scratching re-
sulting in damage to superficial and
deeper layers of the skin) following exci-
totoxic SCI. Assessment of grooming be-
havior was based on the following clas-
sification scheme: class I: hair removal
over contiguous portions of a der-
matome; class II: extensive hair removal
combined with signs of damage to the
superficial layers of skin; class III: hair
removal and damage to dermal layers of
skin; and class IV: subcutaneous tissue
damage (experiment terminated) (4).
Based on these criteria, all animals were
divided into overgroomers (classes I–IV)
and nonovergroomers. Because over-
grooming usually developed from 8 to
12 days postinjury, the postlesion time
point for rating severity of overgroom-
ing behavior was 12 to 14 days. All ex-
periments were performed in a blinded
manner.
Thermal allodynia (acetone test). To
examine cold allodynia, each animal un-
derwent behavioral testing to determine
sensitivity to thermal stimuli (33). Before
testing, a 15-min quiescent period was
allowed for the animal to acclimate to
the observation chamber. A small
amount of acetone solution (50–100 μL)
was applied to the glabrous skin of the
ipsilateral paw while the animal stood
on an elevated screen. During each test
session, acetone was applied 5 times (at
5-min intervals). The number of re-
sponses was counted between each ap-
plication. Responses included hindpaw
lifting, licking, and withdrawal of the
paw. Three preinjury testing sessions
were used to determine baseline values.
After injury, animals were tested every
third day until day 21, then once every 7
days until day 60. The acetone and von
Frey tests were conducted on separate
days to ensure that they did not interfere
with one another. All tests were per-
formed in a blinded manner.
Mechanical allodynia (von Frey fila-
ment test). The von Frey filament test
has been widely used in experiments
testing mechanical sensitivity following
neurological insult (34-37). In our exper-
iments, we used the von Frey test to as-
sess preinjury mechanical sensitivity,
post-QUIS mechanical sensitivity, and
mechanical sensitivity after ES cell
transplantation or media injection.
Before testing, a 15-min quiescent pe-
riod was allowed for the animal to accli-
mate to the observation chamber.
Filaments with stimulus intensities
ranging from 0.008 to 300 g were ap-
plied to the glabrous skin of each hind
paw 8 times while the animal stood on
an elevated screen. Filaments were ap-
plied to the point of bending, at which
time substantiation of response or non-
response was determined. Responses in-
cluded hindpaw withdrawal and orien-
tation toward the stimulus. During each
test session, the filament that produced
a threshold response (response to stim-
uli 50% of the number of times applied)
in each animal was determined for both
the left and right hindpaws. Three
preinjury testing sessions were used to
determine baseline values. After injury,
animals were tested every third day
until day 21, then once every 7 days
until day 60. This test was used to eval-
uate injury-induced changes in mechan-
ical threshold. All tests were performed
in a blinded manner.
Nociceptive hyperalgesia (formalin
test). The formalin test is a well-
characterized study of nociception
often used to evaluate postinjury pain
(38-43). Attention was paid to the ethical
guidelines for investigations of experi-
mental pain in conscious animals. The
formalin test was conducted according to
a previously established protocol (42).
Before testing, a 15-min quiescent period
was allowed for the animal to acclimate
to the observation chamber. A 25-μL vol-
ume of formalin (5%) in sterile saline
was injected subcutaneously into the
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dorsal surface of the ipsilateral hindpaw
using a 30-G needle. Directly after the
formalin injection, each animal was
placed in a glass cylinder on a flat, reflec-
tive surface to allow clear observation of
the injected paw. Responses included
licking or flicking of the injected paw.
Responses were recorded immediately
after each formalin injection for a period
of 50 min. The total number of responses
recorded during periods of 0–5 min (first
phase) and 15–50 min (second phase)
after formalin injection were measured
as indicators of pain. The formalin test
was performed once on the day of hu-
mane killing in each time point (7, 14, or
60 days). All tests were performed in a
blinded manner.
Tissue Collection and Processing
At 7, 14, or 60 days after ES cell or
media microinjection (10 animals per
survival period), animals were deeply
anesthetized with sodium pentobarbital
(100 mg/kg intraperitoneally). Each ani-
mal was intracardially perfused first
with cold PBS (20 mL) and then cold
4% paraformaldehyde (20 mL) in PBS
(pH 7.4); thoracic and lumbar spinal
cord was removed and postfixed in 4%
paraformaldehyde for 12 to 16 h. Fixed
tissue was stored in 30% sucrose solu-
tion at 4 °C until sectioning.
For immunohistochemistry, tissue was
embedded in tissue-freezing medium
(Triangle Biomedical Science, Durham,
NC, USA), and sectioned into 30-μm
coronal slices using a cryostat microtome
before being processed as free-floating
sections.
Lesion Analysis
Serial reconstruction of the lesion was
done as described previously (32). For
lesion analysis, serial cross-sections of
50 μm were collected in 0.1 M PBS and
mounted on superfrost microscope
slides (Fisher Scientific, Pittsburgh, PA,
USA). All sections were stained with
toluidine blue to identify the area of
neuronal loss and injury. Quantification
of the rostral to caudal extent of QUIS-
induced tissue damage was performed
to compare the hypothesized neuropro-
tective effects of transplanted ES cells.
Pathophysiology of transverse 50-μm
sections were examined using a Nikon
SMZ 800 dissecting microscope. The cri-
teria used to distinguish intact from
damaged tissue included the absence of
neurons and the presence of degenerat-
ing neuron profiles and inflammatory
cells (44,45). Cross-sections of the spinal
cord were examined with light mi-
croscopy, and images of the sections
were taken using Spot digital camera
and Spot Software v. 3.5.8 (Diagnostic
Instruments, Sterling Heights, MI,
USA). Reconstructions of the area of tis-
sue damage was made with ImageJ soft-
ware (NIH). Areas of the gray matter
and the area of the damage at the lesion
epicenter as well as 20 sections rostral
and 20 caudal (2200 μm total length)
were measured using ImageJ. The area
of normal gray matter for each 50-μm
section was compared with the corre-
sponding segmental level of uninjured
control cords to determine the percent-
age of gray matter damage in the in-
jured cord for the area of gray matter in
segments T12 to L3. Mean percentages
of gray matter damage at 50-μm inter-
vals were calculated to create a longitu-
dinal profile of the distribution of dam-
age in each group. In addition, to obtain
an overall descriptor of the amount of
tissue damage, the total lesion volume
was calculated by subtracting the vol-
ume of gray matter remaining in injured
animals from the normal volume as de-
termined from the control. Student
t tests were used to determine differ-
ences in mean lesion volume between
each QUIS-alone group and its corre-
sponding stem cell treatment group.
Approximately 4 mm of tissue was ex-
amined from each animal. If the full ex-
tent of damage could not be examined,
the cord was excluded. The total length
of tissue damage was compared for
ES cell–transplanted and media-injected
mice. Lesion analysis was performed
only for 60-day groups of animals. The
experiments were performed in a
blinded manner.
Immunohistochemistry
Immunostaining of free-floating tho-
racic and lumbar spinal cord sections
(30 μm) was performed as previously de-
scribed (46,47) using the Elite ABC Kit
(Vector Laboratories, Burlingame, CA,
USA). Sections were first washed for 10
min in PBS with 0.3% Triton X-100
(PBST) and then incubated for 30 min in
ice-cold methanol containing 1% H2O2 to
abolish endogenous peroxidase activity.
Sections were then washed twice in PBST
for 10 min, followed by 1-h incubation
with blocking solution, 10% normal goat
serum in PBST. Sections were incubated
with primary antibodies for 1 h to
overnight at 4 °C. They were subse-
quently washed 3 times for 15 min with
PBST and incubated with secondary bi-
otinylated antibodies for 1 h. The sec-
tions were washed again 3 times in PBST
for 15 min and then stained for 2 h using
Elite ABC Kit (avidin-biotinylated horse-
radish peroxidase complex) (Vector
Laboratories). After staining, tissue anti-
gens were visualized with a DAB
Substrate Kit for Peroxidase (Vector
Laboratories). Stained free-floating sec-
tions were placed on superfrost micro-
scope slides (Fisher Scientific) and air-
dried overnight. Slides were soaked in
Citrisolve (Fisher Scientific) for two 15-
min washes and permanently mounted
with Permount (Fisher Scientific).
Controls included tissue samples
processed without primary antibody,
without secondary antibody, and with-
out ABC complex. All experiments were
repeated 3 times.
Immunocytochemistry
Immunostaining of ES cells was per-
formed as previously described (29). ES
cells were grown on gelatin-coated cov-
erslips. After differentiation induction
with RA, ES cells were fixed with 4%
paraformaldehyde in PBS and pro-
cessed using the Elite ABC Kit. Cells
were washed for 10 min in PBST and
then incubated for 10 min in 80%
methanol containing 1% hydrogen per-
oxide. The cells were then washed
twice in PBST for 5 min before blocking
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with avidin and biotin for 15 min each,
followed by 1-h incubation with block-
ing solution (10% normal goat serum in
PBST). The cells were then incubated
with primary antibodies 1 h to
overnight at 4 °C. After incubation, pri-
mary antibodies were removed and
cells were washed 3 times in PBST for
10 min each. The cells were subse-
quently incubated with secondary anti-
bodies from the Elite ABC kit for 1 h.
Secondary antibodies were removed
and the cells were washed 3 times in
PBST for 10 min each. The cells were
then incubated for 1 h in ABC reagent.
ABC reagent was removed and the cells
were washed 3 times in PBS for 5 min
before being stained with DAB. After
DAB staining, the cells were washed in
distilled water. Slides were allowed to
air-dry overnight. Dry slides were
soaked in Citrisolve (Fisher Scientific)
for 15 min, and a coverslip was
mounted using DPX (Fluka Biochemika,
Switzerland). Immunostaining controls
included cell samples without primary
antibodies, without secondary antibod-
ies, and without ABC complex.
Immunofluorescence
To study coexpression of antigens, cul-
tured ES cells and tissue from spinal
cords were stained using immunofluores-
cent, dual-staining techniques. Secondary
antibodies conjugated with fluorescent
dyes FITC (green fluorescence) and Texas
red (red fluorescence) were used to show
intracellular localization of diverse anti-
gens of interest. Counterstaining with
DAPI, a nuclear dye (blue fluorescence),
was also performed.
Antibodies
The following antibodies were used for
immunostaining procedures. Anti- GFP
(chicken; polyclonal; 1:1000) (Chemicon),
neuron-specific anti–MAP-2 rabbit poly-
clonal antibodies (immunoreactivity with
neuronal MAP-2A and MAP-2B; 1:2000)
(Chemicon), neuron-specific anti-NeuN
(mouse; polyclonal; 1:500) (Chemicon),
glial specific anti-GFAP (rabbit; polyclonal;
1:1000) (Chemicon), and mouse mono-
clonal antibodies against Lim2 (1:100)
(Developmental Studies Hybridoma Bank)
to detect precursors of dorsal interneu-
rons, mouse monoclonal MNR2/HB9
(1:100) antibodies to detect motoneuron
progenitors (Developmental Studies
Figure 1. An example of excessive groom-
ing behavior displayed by 60% of the
media-injected mice. Excessive grooming
behavior was not observed in ES
cell–transplanted mice.
Table 1. Presence of excessive grooming behavior in ES cell–transplanted and media-
injected mice.
Grooming Behavior Observed
Total No. Normal, Excessive Grooming (class I–IV), n (%)
Treatment Mice n (%) I II III IV
Predifferentiated ES cells 28 28 (100) 0 0 0 0
Media 30 12 (40) 0 7 (23.3) 11 (36.7) 0
Figure 2. Total number of responses to room temperature (23 °C) acetone. (A) Seven
days after ES cell or media treatment. (B) Fourteen days after ES cell or media treatment.
(C) Sixty days after ES cell or media treatment. Black arrow, QUIS injury; gray arrow, ES cell
transplantation or media injection; , ES cell–transplanted mice; , media-injected mice.
**P < 0.001.
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Hybridoma Bank), and anti-synapsin rab-
bit polyclonal antibodies 1:1000 (Sigma);
antisynaptophysin mouse monoclonal
1:400 (Sigma), anti-PSD95 monoclonal
1:500 (Upstate Biotechnology, Waltham,
MA, USA), and anti-phosphohistone H3
(Ser10) mouse monoclonal 1:100 (Cell
Signaling Technology, Beverly, MA, USA)
as a marker of mitotic cells. For immuno-
fluorescence all primary antibodies were
applied in 1:100 dilution.
Microscopy
All slides were examined under an
Olympus IMT-2 inverted fluorescent mi-
croscope. Images were photographed
using a Spot digital camera and Spot
Software v. 3.5.8 (Diagnostic Instruments,
Sterling Height, MI, USA).
Statistical Analysis
Statistical analysis was performed with
1-way ANOVA, and a posttest Newman-
Keuls multiple comparison test was per-
formed using GraphPad Prism (v. 3.00





Animals were assessed daily for the
presence of excessive grooming behavior
(self-directed biting and scratching re-
sulting in damage to superficial and
deeper layers of the skin) following exci-
totoxic SCI. Because overgrooming usu-
ally developed from 8 to 12 days postin-
jury, the postlesion time point for rating
severity of overgrooming behavior was
12 to 14 days. Of the 28 animals receiv-
ing SCI and stem cell treatment, none de-
veloped excessive grooming behavior,
whereas 18 of the 30 animals receiving
media injections (60.0%) developed ex-
cessive grooming behavior with latency
of onset ranging from 8 to 12 days
postinjury (P < 0.0001) (Table 1). The ex-
cessive grooming behavior targeted the
abdomen, hip, and thigh areas (Figure 1).
These areas corresponded to der-
matomes associated with spinal seg-
ments at or caudal to the site of injury
(T13 to L2). All grooming observed in
media-injected mice was rated in sever-
ity as class II or III. Excessive grooming
behavior is associated with the second-
ary injury cascade, and its onset strongly
correlates to the amount of tissue dam-
age at associated spinal segments.
Excessive grooming behavior subsided
approximately 7 weeks after injury in
media-transplanted mice. The lack of
overgrooming in ES cell–transplanted
animals strongly suggests that stem cells
transplanted at the site of injury greatly
reduced the damage following excito-
toxic SCI.
Thermal allodynia (acetone test).
Intact animals did not respond to stimu-
lus at any time point. Before injury, ap-
plication of room temperature acetone
did not evoke response in any animals.
After SCI, all groups of animals initially
exhibited a highly significant (P < 0.001)
number of responses compared with
baseline values (Figure 2A-C). There
were no statistical differences (P > 0.05)
between experimental groups before
treatment with stem cells or media. After
ES cell transplantation (day 0, gray
arrow), the number of responses imme-
diately decreased, indicating a reduction
of thermal allodynia. The numbers of re-
sponses recorded were consistent in all
ES cell groups tested and returned to
Figure 3. Allodynia to mechanical stimuli applied to the ipsilateral hindpaw for ES
cell–transplanted and media-injected mice. (A) Seven days after ES cell (n = 7) or
media (n = 10) treatment. (B) Fourteen days after ES cell (n = 10) or media (n = 10)
treatment. (C) Sixty days after ES cell (n = 11) or media (n = 10) treatment. y-axis, per-
cent of preinjury baseline values; , ES cell–transplanted mice; , media-injected
mice; black arrows, QUIS injection; gray arrows, ES cell transplantation or media injec-
tion. *P < 0.01, **P < 0.001.
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preinjury baseline levels at approxi-
mately 12 days after ES cell transplanta-
tion (P > 0.05), where they remained
throughout the remainder of the experi-
ment. Groups treated with media after
SCI continued to show elevated sensitiv-
ity to thermal stimuli, indicated by am-
plified numbers of responses. The num-
ber of responses in media-treated
animals was significantly higher (P <
0.001) than in ES cell–treated animals in
every testing session through the remain-
der of the experiment (56 days). Media-
injected animals did not return to base-
line values at any point following injury
(Figure 2B, C).
Mechanical allodynia (von Frey
filament test). Following QUIS injury,
all mice demonstrated hypersensitivities
to mechanical stimuli. The filament in-
tensities required to elicit a response
from each animal were much lower
for the ipsilateral hindpaw in both
ES cell–transplanted and media-injected
mice. By 12 days after treatment with
stem cells, the ipsilateral values returned
to normal preinjury levels (Figure 3B, C).
The sensory threshold of the ipsilateral
hindpaw of media-treated animals did
not return to baseline values during the
observation/testing period (56 days). The
effect of QUIS injury was less apparent
in contralateral hindpaws (Figure 4A-C).
Media-injected mice significantly dif-
fered from ES cell–transplanted mice
(P < 0.01) at 9, 21, and 28 days. Signifi-
cance (P < 0.001) was observed for the
contralateral hindpaw between ES cell–
and media-treated mice at 6, 12, 15, 18,
35, 42, 49, and 56 days.
Nociceptive hyperalgesia (formalin
test). The injection of formalin resulted
in a progressive biphasic response of the
Figure 4. Allodynia to mechanical stimuli applied to the contralateral hind paw in ES
cell transplanted and media injected mice. (A) Seven days after ES cell (n = 7) or
media (n = 10) treatment. (B) Fourteen days after ES cell (n = 10) or media (n = 10)
treatment. (C) Sixty days after ES cell (n = 11) or media (n = 10) treatment. y-axis, per-
cent of preinjury baseline values; , ES cell–transplanted mice; , media-injected
mice; black arrows, QUIS injection; gray arrows, ES cell transplantation or media injec-
tion. *P < 0.01, **P < 0.001.
Figure 5. Number of responses to formalin
injection over a 50-min observation pe-
riod. (A) Seven days after ES cell (n = 7)
and media (n = 10) treatment and intact
mice (n = 5). (B) Fourteen days after ES
cell (n = 10) and media (n = 10) treat-
ment and intact mice (n = 5). (C) Sixty
days after ES cell (n = 11) and media (n =
10) treatment and intact mice (n = 5).
, ES cell–transplanted mice; , media-
injected mice; , intact mice. *P < 0.01,
**P < 0.001.
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injected paw. The early phase began im-
mediately after formalin injection and
peaked during the first 5 min. The late
phase followed, lasted the remainder of
the observation period (50 min), and
peaked between 20 and 40 min.
Figure 5A shows the results of the
formalin test 7 days after transplanta-
tion of ES cells or media injection com-
pared with uninjured, intact mice.
ES cell–treated mice responded simi-
larly to intact mice. Mice that received
media injections showed significantly
(P < 0.001) more responses than intact
or stem cell–transplanted mice at both
early and late phases.
Figure 5B demonstrates the results of
the formalin test 14 days after transplan-
tation of ES cells or media injection
compared with uninjured, intact mice.
Media-injected animals demonstrated
a significantly (P < 0.001) elevated
response to the formalin injection in
both early and late phases; however,
ES cell–transplanted mice had signifi-
cantly (P < 0.001) fewer responses than in-
tact mice in the initial nociceptive phase.
Figure 5C illustrates the results of the
formalin test 60 days after transplanta-
tion of ES cells or media injection com-
pared with uninjured, intact mice. As in
the 7- and 14-day groups, the number of
responses recorded for the 60-day group
of media-injected animals was signifi-
cantly (P < 0.001) higher than intact or
stem cell–transplanted animals at the
later (inflammatory) phase of testing.
The number of early-phase responses, al-
though somewhat elevated in media-in-
jected mice, showed no statistical signifi-
cance (P > 0.05) compared with intact
animals. ES cell–transplanted mice dis-
played significantly (P < 0.001) fewer
early-phase responses than intact mice.
Lesion analysis
Previous research using the excitotoxic
SCI model suggests a correlation be-
tween the onset of pain-related behaviors
and the extent of tissue damage (48-50).
A critical threshold of tissue damage ap-
peared vital for initiation of spontaneous
pain behaviors. Lesion analysis showed
that at 60 days after ES cell transplanta-
tion or media injection, there was a dra-
matic difference in the longitudinal ex-
tent of tissue damage. The tissue damage
observed in ES cell–treated mice, 60 days
posttransplantation, extended 1118 ± 83.7
μm compared with 2176 ± 142.3 μm in
media-injected mice (P < 0.0001). Given
that none of the ES cell–transplanted
mice displayed evidence of excessive
grooming, it is hypothesized that the
critical threshold of tissue damage re-
quired for the onset of overgrooming be-
havior was never reached. Previous stud-
ies have also suggested that the amount
of tissue damage at the epicenter of in-
jury is critical to the onset of sponta-
neous overgrooming behaviors (48-50).
We also assessed the volume of the re-
maining gray matter in an unpaired
t test. The analysis of spared tissue at 60
days revealed that mice transplanted
with ES cells suffered significantly less
tissue damage than mice that received
media injections. Transplantation of ES
cells did reduce the overall size of the le-
sion cavity, as demonstrated by a larger
remaining volume of tissue. Statistical
comparisons at 60 days revealed that
whereas the average volume of gray
matter in intact mice was 91.82 ± 2.250
μm3, the volume of spared gray matter in
QUIS-injured mice was significantly de-
creased at 33.26 ± 1.538 μm3 (P < 0.0001).
Mice treated with stem cells had a mark-
edly higher volume of spared gray mat-
ter (58.92 ± 5.095 μm3; P < 0.005) then
Figure 6. Volume of spared gray matter in
ES cell–transplanted and media-injected
mice at 60 days.
Figure 7. Fluorescence microscopy of GFP-expressing cells 14 days after ES cell trans-
plantation (A-C). (A) GFP cells fill epicenter of injury. Arrow indicates transplanted cells.
(B) GFP cells migrating into surrounding tissue. Arrow indicates origin of migrating GFP-
positive cells. (C) GFP cell with processes. Arrows indicate cell body and processes.
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nontreated mice (Figure 6). The results
indicate that transplantation of ES cells
significantly reduced the extent of gray
matter loss following injury.
Histological Analysis
Analysis of the spinal cords showed a
difference between ES cell–transplanted
and media-injected animals. Fluorescent
microscopy showed that the lesion cav-
ity created by QUIS was filled with GFP-
positive cells in stem cell–treated ani-
mals (Figure 7A). The transplanted cells
appeared to fill the lesion area and to
survive. Using high magnification at day
7, potential neuronal processes were ob-
served branching from GFP-positive
cells (Figure 7C). Immunohistochemical
staining of spinal cord showed little spe-
cific staining against NeuN or GFAP
antibodies at the site of the injury in
media-treated animals at 7 days. Most
media-injected animals had a fluid-filled
area at the site of injection (resembling
a syrinx) or collapse of the dorsal horn
at 14 days (Figure 8A, C). In stem
cell–treated animals, however, the col-
lapse of the dorsal horn was less pro-
nounced and NeuN-positive cells were
visible in the dorsal horn (Figure 8B). In
media-injected mice at 60 days, damage
was limited to a severe narrowing of the
neck of the ipsilateral dorsal horn
(Figures 9A, C), whereas in ES cell–
transplanted mice (Figure 9B), NeuN
staining revealed somewhat shrunken
dorsal horn ipsilateral to injury. These
histological differences between media-
and stem cell–injected animals corre-
spond to the previous lesion analysis
(Figure 6). Immunostaining against GFP
and immunofluorescence against NeuN
and GFAP demonstrated that the trans-
planted cells acquired neuronal pheno-
type and survived in the dorsal horn
up to 60 days posttransplantation
(Figure 10, upper panel). Conversely,
some cells with acquired neuronal phe-
notype migrated into ipsilateral ventral
horn (Figure 10, lower panel), which
was visualized by MAP-2 neuron-
specific staining. The histology of the
spinal cord revealed evidence that sup-
ports our behavior data. It was apparent
that less tissue damage was sustained in
ES cell–transplanted mice, indicating a
neuroprotective effect.
Cytological Analysis
Daily observations were made using
an inverted microscope during differenti-
ation induction of ES cells. Digital im-
ages were taken of live cultures to record
the progression of cells during the differ-
entiation process. Immunocytochemical
analysis after differentiation provided
evidence that our ES cells displayed neu-
ral properties.
During differentiation induction, ES
cells formed free-floating cell aggregates,
or embryoid bodies (Figure 11A). We
also examined mitotic figures during the
treatments using immunostaining with
anti-phosphohistone H3 (Ser10) antibod-
ies. Phosphorylation at Ser10 of histone
H3 is tightly correlated with chromo-
some condensation during mitosis and
serves as a marker of dividing cells
(Figure 11B). By the late stages of the
4–/4+ differentiation protocol, extensive
neural clusters were observed in culture
(Figure 11E).
The purpose of differentiating ES
cells was to generate cell types suitable
for transplantation into the spinal cord
that might provide recovery of sensory
function following injury. Therefore,
Figure 8. Immunohistochemical staining 14 days after media injection (A, C) and ES cell
transplantation (B, D). (A) Visualization of NeuN-positive cells in media-injected spinal
cord. Arrows indicate lesion and the absence of neuronal staining ipsilateral to injury.
(B) Visualization of NeuN-positive cells in ES cell–transplanted spinal cord. Arrows indi-
cate side ipsilateral to injury and cell transplant. (C) Visualization of GFAP-positive cells
in media-injected spinal cord. Arrows indicate lesion ipsilateral to injury and increased
intensity of GFAP immunostaining ipsilateral to injury. (D) Visualization of GFAP-positive
cells in ES cell–transplanted spinal cord. Arrows indicate dorsal horn preservation on
side ipsilateral to injury and cell transplant.
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immunophenotyping of differentiated
cells prepared to be transplanted was
performed on the same day as trans-
plantation. The FACS analysis showed
that the culture prepared for transplan-
tation contained 8.430% ± 0.8514% of
glial cell and 51.43% ± 2.944% of neu-
rons, with remaining cells not yet ex-
pressing any specific neural markers.
Of neurons there were 33.75% ± 2.903%
LIM-2–positive cells and 32.74% ±
5.839% HB9-positive cells. These differ-
entiated cells displayed positive im-
munostaining against synapsin (Figure
11D). In addition, immunostaining with
antibodies against the specific marker
of progenitors/young dorsal interneu-
ron LIM-2 and against the specific
marker of progenitors/young motor
neurons HB9 confirmed that our proto-
col enabled differentiation of some cells
into dorsal interneuron progenitors
(Figure 11F), as well as into motor
neurons (29).
DISCUSSION
The results of this study demonstrate
that transplantation of predifferentiated
ES cells can attenuate both evoked and
spontaneous pain behaviors following
excitotoxic SCI. After stem cell transplan-
tation, both mechanical and thermal
thresholds returned to preinjury values,
and excessive grooming did not develop.
The immediacy of neuroprotection and
the sustained antinociception after ES
cell transplantation demonstrate the po-
tential therapeutic value ES cell trans-
plantation may provide following SCI.
This study utilized an excitotoxic
model of SCI to examine the effects of
predifferentiated embryonic stem cells
on post-SCI pain behaviors. The excito-
toxic model is relevant based on findings
indicating that QUIS produces pathologi-
cal and behavioral changes comparable
to those following ischemic and trau-
matic human SCI (12,44). The excitotoxic
model of SCI has been widely used for
the study of the secondary pathology of
SCI. Moreover, this model of injury re-
sults in behavioral sequelae that include
allodynia, hyperalgesia, and sponta-
neous pain behaviors. Using the excito-
toxic SCI model, studies have examined
modalities that may limit secondary
damage and provide antinociception for
chronic pain (31,32,51,52). However,
there have been no studies showing alle-
viation of chronic pain following ES cell
transplant.
One of the key features of secondary
damage following SCI is inflammation
(53,54). The presence of an inflammatory
cascade following QUIS injury is be-
lieved to be a major contributor to the
secondary neuronal injury and onset of
pain-related behaviors. Moreover, the de-
velopment of inflammation can lead to
the induction of pro-inflammatory cy-
tokines and may provide a link between
inflammation and the development of
chronic pain (32). The patterns observed
in the inflammatory phase of the forma-
lin test suggest that ES cells may be di-
rectly or indirectly inhibiting or interfer-
ing with peripheral inflammatory
signaling. The secondary inflammatory
reaction is thought to be due to several
peripheral chemical mediators released
from damaged cells, including histamine,
kinin, serotonin, and prostaglandin (42).
These mediators take part in the inflam-
matory response and are able to stimu-
late nociceptors. In the formalin test,
ES cell–transplanted mice displayed re-
sponse patterns similar to those of intact
mice during this inflammatory phase,
whereas media-injected mice showed
Figure 9. Immunohistochemical staining 60 days after media injection (A, C) and ES cell
transplantation (B, D). (A) Visualization of NeuN-positive cells in media-injected spinal
cord. Arrows indicate neuronal loss in all laminae ipsilateral to injury. (B) Visualization of
NeuN-positive cells in ES cell–transplanted spinal cord. Arrows indicate side ipsilateral to
injury. Note increased number of immunostained neuronal cells. (C) Visualization of GFAP-
positive cells in media-injected spinal cord. Arrows indicate areas of high staining intensity
in side ipsilateral to injury. (D) Visualization of GFAP-positive cells in ES cell–transplanted
spinal cord. Arrows indicate increased intensity of GFAP staining in only a small area on
side ipsilateral to injury and cell transplant.
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significantly elevated frequency of re-
sponses. Moreover, ES cell–transplanted
mice displayed fewer responses during
the inflammatory phase of the formalin
test in each subsequent time point exam-
ined (7 < 14 < 60 days). The decrease in
frequency of responses in subsequent
time points after transplantation suggests
that our ES cells may be capable of in-
hibiting or disrupting peripheral inflam-
matory signals.
In the present experiments, the mor-
phological characteristics following QUIS
and media microinjections were similar
to previous reports (4,12,32,44,49,55,56).
Spinal cord segments at or near QUIS in-
jection sites contained hypertrophied
neuronal profiles and increased staining
for GFAP, especially in areas of neuronal
degeneration and border areas of spinal
lesions. Morphological changes were di-
rectly related to the duration of survival
following injury. ES cell–transplanted
mice had less intense staining against
GFAP. Additionally, NeuN immunostain-
ing showed greater neuronal survival in
ES cell–transplanted mice. These experi-
mental data suggest that transplanted ES
cells reduced neuronal cell death and
glial scarring associated with secondary
injury.
Given that none of the ES cell–
transplanted mice displayed evidence
of excessive grooming, it is hypothe-
sized that the critical threshold of tissue
damage required for the onset of over-
grooming behavior was never reached.
Previous studies have also suggested
that the amount of tissue damage at the
epicenter of injury is critical to the onset
of spontaneous overgrooming behaviors
(48-50). Correspondingly, the size of the
lesion cavity at the epicenter of injury
was reduced after stem cell transplanta-
tion in our experiments.
The immediacy of the behavioral
improvements observed in ES cell–
transplanted animals suggests that other
factors are at work in providing recov-
ery after injury. In a collaborative study,
it was recently shown that murine ES
cells, differentiated via the same modi-
fied 4–/4+ protocol, could significantly
lessen the sensorimotor impairments
and reduce the extent of cortical damage
observed following traumatic brain in-
jury (27). The rapid and early (day 2 to 3
after transplantation) sensorimotor im-
provements observed in that study may
be attributed not to reestablishment of
host circuitry, but rather to some neu-
rotrophic influences. Similar improve-
ments have been demonstrated by ad-
ministration of neuroprotective agents
(for example, MgCl2 and vitamin B3),
suggesting that neuroprotective mecha-
nisms may be involved (30,57-59).
Several studies have shown that media
from neural cell cultures provides bene-
ficial effects by transfer of neurotrophic
factors (17,60). Indeed, in a recent
follow-up study (unpublished observa-
tions), we showed that transplanted ES
cells are a source of BDNF and IL-6 and
increased cAMP in the injured host cells
in the spinal cord.
In this study, the observed improve-
ments were not only rapid but also long
lasting. All spontaneous and evoked pain
behaviors were attenuated, the size of
the lesion was greatly reduced, and im-
munostaining revealed survival of the
transplanted and differentiated cells into
neurons cells up to 60 days.
The results of this study have shown
that transplantation of predifferentiated
ES cells holds great therapeutic poten-
tial in preventing chronic pain follow-
ing excitotoxic spinal cord injury and
alleviating injury-related allodynia and
hyperalgesia.
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arrows indicate neurons.
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